Advertisement

SANTA ROSA, Calif., Aug. 16, 2011 /PRNewswire/ -- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant dose-dependent activation of T-cytotoxic cells and Natural Killer (NK) cells. The NK-cell's cancer killing activity was demonstrated against live leukemia cancer cells. The study is published in the journal BMC Complementary and Alternative Medicine. The research focuses on MCP's immunostimulatory properties in human blood samples, resulting in modulation of different arms of the immune system. Immune researchers at the Dharma Biomedical LLC (Miami, FL) are excited. "The dramatic ability of MCP to activate different components of both the innate (NK-cells) and adaptive (T-cytotoxic) arms of the immune system, demonstrates that MCP can be used in a very strategic manner to support immune function, which may prove useful for a variety of immune compromised health situations," says lead researcher Dr. Steve Melnick.MCP induced an increase in B-cells, T-cytotoxic cells, and NK-cells in a dose dependant manner, meaning the higher the dosage, the greater the effect. Researchers demonstrated that MCP induced a dramatic ten-fold increase in NK-cell activation, and furthermore a significant 53.6% increase in the NK-cells' functional ability to identify and destroy leukemia cancer cells.

Mechanism of Action (How MCP Works)

Melnick further explains, "The Modified Citrus Pectin used in this study consists of various polysaccharides that come in contact with different receptors or proteins on the membranes of immune cells. The immune cells become activated as a consequence of this very specific interaction." Melnick continues, "What I found impressive was the selectivity, and in those cases the magnitude

'/>"/>

SOURCE

Advertisement
Advertisement